HFS
TAK icon

Horizon Financial Services’s Takeda Pharmaceutical TAK Stock Holding History

Horizon Financial Services’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208 Buy
+13
New +$215 ﹤0.01% 586

Other funds holding TAK

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SCP
Sivia Capital Partners Mill Valley, California $822M AUM 48.82% 1-Year Est. Return

Horizon Financial Services's TAK Position: Q2 2026 in Review

Horizon Financial Services opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 13 shares worth $208. The stake represents ﹤0.01% of the portfolio and ranks #586 among its holdings.

124 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Horizon Financial Services held 13 shares of Takeda Pharmaceutical worth $208 as of Q2 2026.
  • Takeda Pharmaceutical was a new Horizon Financial Services position in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Horizon Financial Services's portfolio in Q2 2026, its #586 holding.
  • 124 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Horizon Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.